Insulin sensitivity in type 1 diabetes pregnancies
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how well the body uses insulin in women who had type 1 diabetes during a recent pregnancy. If you used a Dexcom CGM and Tandem insulin pump while pregnant, your data could help researchers better understand insulin needs in pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were pregnant at some point in the last 8 years
- You had type 1 diabetes for at least one year before that pregnancy
- You used a Dexcom continuous glucose monitor (CGM) and a Tandem insulin pump during your pregnancy
- You are willing to share your CGM and pump data from that pregnancy with the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
This study helps pregnant women with type 2 diabetes receive better blood sugar management during pregnancy. Researchers will monitor you and your baby closely to see how well the treatment plan works and keeps both of you healthy.
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
This study tests if an automated insulin delivery system can help manage blood sugar levels during labor and delivery in pregnant women with type 1 diabetes. If successful, it could make the process safer and easier.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests if a special monitoring system can help people with type 1 diabetes use SGLT2i medications safely, alongside insulin and a continuous glucose monitor.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.